
About this episode
For decades, the best drug therapies for treating depression, like SSRIs, have been based on the idea that depressed brains don’t have enough of the neurotransmitter serotonin. Yet for almost as long, it’s been clear that simplistic theory is wrong. Recent research into the true causes of depression is finding clues in other neurotransmitters and the realization that the brain is much more adaptable than scientists once imagined. Treatments for depression are being reinvented by drugs like ketamine that can help regrow synapses, which can in turn restore the right brain chemistry and improve whole body health.
In this episode, John Krystal, a neuropharmacologist at the Yale School of Medicine, tells Steve Strogatz about the new findings in mental health research that are revolutionizing psychiatric medication.
Get every episode summarized
Each time The Joy of Why publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Joy of Why

Live from ICM 2026: What Is Math For in the Age of AI?
The Joy of Why

Are We Thinking Correctly about AI Intelligence?
The Joy of Why

How Does Touch Lead To Pain Or Pleasure?
The Joy of Why

How Fast Is the Universe Really Expanding?
The Joy of Why